MR [Mindray Medical International] 424B5: CALCULATION OF REGISTRATION FEE Proposed maximum Proposed maximum

[CALCULATION OF REGISTRATION FEE Proposed maximum Proposed maximum Title of each class of Amount to be offering price pergregate offering Amount of securities to be registered RegisteredS price registration fee(3) ClassA ordinary shares, par value HK$0.001 per share(1) 4,600,000 (2) $ 38.20 $ 175,720,000 $ 12,528.84 (1) American depositary shares, orSs, issuable upon deposit of]

MR [Mindray Medical International] 6-K: our goals and strategies; our future business development,

[our goals and strategies; our future business development, financialndition and results of operations,luding our unaudited operating results for the year ended December31, 2009; the projected growth of the medical device industry in China and internationally; the effects of the current global economic crisis and global macroeconomicnditions on our business;]

CXDC [China XD Plastics Co] 424B3: Registration No. 333-164027 Prospectus 3,301,739 Shares of Common

[Registration No. 333-164027 Prospectus 3,301,739 Shares of Common Stock CHINA XD PLASTICS COMPANY LIMITED We are registering 3,301,739 shares (the “Shares”) of our common stock, par value $0.0001 per share (the “Common Stock”) for sale by the selling stockholders set forth herein, issuable, from time to time, upon the conversion of Series C Convertible Preferred Stock, par value $0.0001 per]

By | 2016-03-25T18:55:55+00:00 March 8th, 2010|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: , , , , , |0 Comments

YGE [YINGLI GREEN ENERGY] 6-K: (Original Filing)

[Yingli Green Energy Reports Fourth Quarter and Full Year 2009 Results Fourth Quarter PV Module Shipmentsreased by 15.7% Quarter over Quarter BAODING, China, March8, 2010 Fourth Quarter 2009nsolidated Financial and Operating Highlights Total net revenues were RMB 2,530.9million (US$370.8million) and PV module shipment volumereased by 15.7% quarter over quarter, reaching a historical high.] [Yingli Green Energy Announces 300 MW PANDA Mono-Crystalline BAODING, China, March8, 2010 300 MW PANDA Mono-Crystalline Manufacturingpacity Expansion at Baoding Headquarters Yingli Green Energy announced its plan to build PANDA mono-crystalline silicon-based manufacturing lines with annual productionpacity of 300 MW in each of mono-crystalline ingots and wafers, cells and modules at its Baoding headquarters, through]

By | 2016-02-04T01:31:32+00:00 March 8th, 2010|Categories: Chinese Stocks, SEC Original, YGE|Tags: , , , , , |0 Comments

YGE [YINGLI GREEN ENERGY] 6-K: Yingli Green Energy Reports Fourth Quarter and Full

[Yingli Green Energy Reports Fourth Quarter and Full Year 2009 Results Fourth Quarter PV Module Shipmentsreased by 15.7% Quarter over Quarter BAODING, China, March8, 2010 Fourth Quarter 2009nsolidated Financial and Operating Highlights Total net revenues were RMB 2,530.9million (US$370.8million) and PV module shipment volumereased by 15.7% quarter over quarter, reaching a historical high.] [Yingli Green Energy Announces 300 MW PANDA Mono-Crystalline BAODING, China, March8, 2010 300 MW PANDA Mono-Crystalline Manufacturingpacity Expansion at Baoding Headquarters Yingli Green Energy announced its plan to build PANDA mono-crystalline silicon-based manufacturing lines with annual productionpacity of 300 MW in each of mono-crystalline ingots and wafers, cells and modules at its Baoding headquarters, through]

By | 2016-02-04T01:32:01+00:00 March 8th, 2010|Categories: Chinese Stocks, Webplus ver, YGE|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] SC 13G/A: (Original Filing)

[SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock 830884102 May05,2009 o x o * The remainder of thisver page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a]

By | 2016-02-05T04:31:49+00:00 March 8th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] SC 13G/A: SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of

[SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock 830884102 May05,2009 o x o * The remainder of thisver page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a]

By | 2016-02-05T04:32:39+00:00 March 8th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar